Skip to content

Further development and validation of the daily hay fever forecast by symptom monitoring using modern information- and communication technology

Further development and validation of the daily hay fever forecast by symptom monitoring using modern information- and communication technology - Development and validation of the daily hay fever forecast

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30329
Enrollment
80
Registered
2007-03-12
Start date
2007-03-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hay fever rhinoconjunctivitis

Interventions

None listed

Sponsors

Astma Fonds
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: rhinoconjunctivitis due to grass pollen allergy age between 14 and 60 living in Zuid Holland

Exclusion criteria

Exclusion criteria: pregnant or breastfeeding serious illness (e.g.malignancy, autoimmune disease, cardiovascular morbidity) asthma treated otherwise than B2 mimetics on demand disorders of the nose interfering with hay fever symptoms (nasal polyps, concha hypertrophia, septumdeviation exceeding 50%)

Design outcomes

Primary

MeasureTime frame
To develop and validate a multi-day hay fever forecast

Secondary

MeasureTime frame
1. To (re)validate the current hay fever forecast using modern communication technology 2. To develop a system in which patients can enter daily symptom scores by mobile telephone or the internet in order to obtain prompt and therefore more reliable registration of symptoms.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)